Medica Group Limited
Activities of head offices · Hastings
ActiveUnited KingdomIncorporated 2013Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£24,097,000
Cash
£329,000
Turnover
—
Profit / loss
−£8,717,000
Current assets
£34,197,000
Creditors < 1 year
£73,001,000
Equity
£24,097,000
Average employees
13
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-31Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | £24,097,000 | £32,838,000 |
| Equity | £24,097,000 | £32,838,000 |
| Share capital | £253,000 | £253,000 |
| Retained earnings | −£7,101,000 | £1,640,000 |
| Assets | ||
| Fixed assets | £62,901,000 | £62,817,000 |
| Investments | £62,794,000 | £62,817,000 |
| Current assets | £34,197,000 | £21,459,000 |
| Cash at bank | £329,000 | £2,258,000 |
| Debtors | £33,868,000 | £19,201,000 |
| Liabilities | ||
| Creditors within one year | £73,001,000 | £51,438,000 |
| Net current assets | −£38,804,000 | −£29,979,000 |
| Profit & loss | ||
| Administrative expenses | £5,602,000 | £4,082,000 |
| Other operating income | £1,445,000 | — |
| Operating profit | −£4,157,000 | −£4,082,000 |
| Interest receivable | £1,447,000 | £1,420,000 |
| Interest payable | £6,114,000 | £3,680,000 |
| Profit before tax | −£8,824,000 | −£6,342,000 |
| Tax | −£107,000 | −£1,000 |
| Profit / loss | −£8,717,000 | −£6,341,000 |
| Operating costs | ||
| Operating lease charges | £148,000 | £85,000 |
| Audit fees | £199,000 | £261,000 |
| People & pay | ||
| Average employees | 13 | 9 |
| Staff costs | £2,691,000 | £3,192,000 |
| Wages & salaries | £2,384,000 | £2,905,000 |
| Social security costs | £263,000 | £251,000 |
| Pension costs | £44,000 | £36,000 |
| Directors' remuneration | £788,000 | £1,037,000 |
| Highest paid director | £516,000 | £680,000 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Audit
- Subsidiary audit exemption, parent guarantee (s479A)
- Immediate parent
- Moonlight Bidco Limited
- Ultimate parent
- IK IX Master Luxco S.à.r.l
- Accounts
- Full accounts · FRS 101
- Approved
- 2026-09-09, signed by T Hargreaves
Subsidiaries (8)
- Medica Reporting Limited · 100.00 · 6th Floor, One Priory Square, Priory Street, Hastings, TN34 1EA, United Kingdom
- Medica IT Services Limited · 100.00 · 6th Floor, One Priory Square, Priory Street, Hastings, TN34 1EA, United Kingdom
- JCA Seminars Limited · 100.00 · 6th Floor, One Priory Square, Priory Street, Hastings, TN34 1EA, United Kingdom
- Global Diagnostics Ireland Limited · 100.00 · Floor 1, Block 14, Rockfield Medical Campus, Bally, Dublin 16, Ireland
- Global Retinopathy Screening Limited · 100.00 · Floor 1, Block 14, Rockfield Medical Campus, Bally, Dublin 16, Ireland
- Medica US, Inc. · 100.00 · 251 Little Falls Drive, Wilmington, DE 19808, United States
- RadMD Inc · 100.00 · 251 Little Falls Drive, Wilmington, DE 19808, United States
- Medica Australia Pty Limited · 100.00 · c/o KPMG, Level 38, Tower 3 300 Barangaroo, Australia
Borrowings (3)
- Unitranche facility · £84.3m · fully drawn as at 31 December 2025 · secured on The Company has granted security relating to a Unitranche facility
- Acquisition Capex Facility (ACF) · up to £25m · SONIA plus a margin of between 2.75% and 3.75% · secured on The Company has granted security relating to a Unitranche facility
- Revolving Credit Facility (RCF) · £4m · SONIA plus a margin of between 2.75% and 3.75% · £4m was drawn on the RCF as at 31 December 2025 · secured on The Company has granted security relating to a Unitranche facility
Share classes (1)
- 126,483,063 Ordinary share capital of 0.2p
Events after the year end (1)
- On 13th February 2026, the Company acquired the entire issued share capital of Axonmedical Limited and Mitis Health Limited for a combined consideration of approximately £12m. These acquisitions were funded by drawing down on existing borrowing facilities.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
3 outstanding chargesAll Assets · created 2023-10-13
—
OutstandingFixed · created 2023-10-13
—
OutstandingFixed · created 2023-10-13
—
OutstandingShow 3 satisfied / released
Fixed · created 2021-05-06 · satisfied 2023-09-27
—
SatisfiedAll Assets · created 2021-05-06 · satisfied 2023-09-27
—
SatisfiedFixed · created 2021-05-06 · satisfied 2023-09-27
—
Satisfied